Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 9Neoplasms 6Anxiety Disorders 4Pain 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Multiple Myeloma 2Fatigue 2Depression 2Carcinoma, Ovarian Epithelial 2Wounds and Injuries 1Vomiting 1Urinary Bladder Neoplasms 1Thrombocythemia, Essential 1Stroke 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sleep Initiation and Maintenance Disorders 1Sezary Syndrome 1Sepsis 1Recurrence 1Pulmonary Disease, Chronic Obstructive 1Prostatic Neoplasms 1Primary Myelofibrosis 1Popliteal Cyst 1Polycythemia Vera 1Peripheral Nervous System Diseases 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Parasomnias 1Ovarian Neoplasms 1Osteoarthritis, Knee 1

Interventions

Psychiatric Rehabilitation 3Early Intervention, Educational 3Carboplatin 3Behavior Therapy 3Surgical Procedures, Operative 2Specimen Handling 2Platinum 2Palliative Care 2Methods 2Hyperthermic Intraperitoneal Chemotherapy 2Gene Expression Profiling 2Cisplatin 2Blood Specimen Collection 2taxane 1oregovomab 1motexafin lutetium 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Touch 1Taxes 1Standard of Care 1Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization 1Sodium Chloride 1Serotonin Plasma Membrane Transport Proteins 1Radiotherapy 1Propranolol 1Preoperative Exercise 1Practice Guidelines as Topic 1Polymerase Chain Reaction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Fallopian Tube Neoplasms × Massage × Clear all
NCT00293293 2017-12-28

Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine

Masonic Cancer Center, University of Minnesota

Phase NA Completed
43 enrolled 22 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡